TransCode Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.About RNAZ
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
CEOPhilippe P. Calais
CEOPhilippe P. Calais
Employees7
Employees7
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2016
Founded2016
Employees7
Employees7
RNAZ Key Statistics
Market cap12.58M
Market cap12.58M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume813.58K
Average volume813.58K
High today$15.30
High today$15.30
Low today$14.02
Low today$14.02
Open price$14.24
Open price$14.24
Volume63.58K
Volume63.58K
52 Week high$720.72
52 Week high$720.72
52 Week low$6.15
52 Week low$6.15
RNAZ News
TipRanks 1d
TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own RNAZ. This list is generated using Robinhood data, and it’s not a recommendation.